Where are you?

To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.


Press Release, 03 December 2019

Kuros announces final result of Capital Increase – total gross proceeds of CHF 12.5 million raised

Press Release, 02 December 2019

Kuros announces results of Rights Offering

Press Release, 29 November 2019

Kuros provides an update on the Capital Increase

Press Release, 19 November 2019

Extraordinary General Meeting of Kuros Biosciences approves all resolutions

Press Release, 19 November 2019

Kuros announces the terms of the proposed capital increase through a discounted rights offering expected to raise up to CHF 12 million gross proceeds for the commercialization of its products and the further development of its product candidates

Press Release, 29 October 2019

Kuros convenes Extraordinary General Meeting